Verve Therapeutics, Inc. announced it raised $94 Million in an initial filing from an offering of $94 Million

Jan 22, 2021•over 4 years ago

Amount Raised

$94 Million

BostonHealth Care

Company Information

Company

Verve Therapeutics

Location

500 TECHNOLOGY SQUARE

Boston, Massachusetts, United States

About

Verve was purpose-built to disrupt today’s chronic care model for CVD, with a team of experts in cardiovascular medicine, genetics, gene editing, delivery technologies and drug development. heart-1 is currently enrolling patients with heterozygous familial hypercholesterolemia (HeFH) in the United Kingdom and New Zealand.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Verve Therapeutics, Inc. announced it raised $94 Million in an initial filing from an offering of $94 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information